Tango Therapeutics, Inc. (TNGX) › Shareholders' EquityTango Therapeutics, Inc. (TNGX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $7.91M2020: $38.60M2021: $344.75M2022: $249.48M2023: $253.11M2024: $199.52M2025: $346.18M$346.18M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$346.18M+73.5%2024$199.52M-21.2%2023$253.11M+1.5%2022$249.48M-27.6%2021$344.75M+793.1%2020$38.60M+388.3%2019$7.91M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share